Please ensure Javascript is enabled for purposes of website accessibility

St. Jude Medical Beats on EPS But GAAP Results Lag

By Seth Jayson - Updated Apr 7, 2017 at 12:18PM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Just the facts, Fool.

St. Jude Medical (NYSE: STJ) reported earnings on Oct. 17. Here are the numbers you need to know.

The 10-second takeaway
For the quarter ended Sep. 29 (Q3), St. Jude Medical met expectations on revenues and beat slightly on earnings per share.

Compared to the prior-year quarter, revenue shrank and GAAP earnings per share contracted significantly.

Gross margins expanded, operating margins grew, net margins dropped.

Revenue details
St. Jude Medical reported revenue of $1.33 billion. The 23 analysts polled by S&P Capital IQ expected to see sales of $1.34 billion on the same basis. GAAP reported sales were 4.1% lower than the prior-year quarter's $1.38 billion.

Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.

EPS details
EPS came in at $0.83. The 26 earnings estimates compiled by S&P Capital IQ anticipated $0.81 per share. GAAP EPS of $0.56 for Q3 were 19% lower than the prior-year quarter's $0.69 per share.

Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.

Margin details
For the quarter, gross margin was 73.8%, 10 basis points better than the prior-year quarter. Operating margin was 26.5%, 200 basis points better than the prior-year quarter. Net margin was 13.3%, 310 basis points worse than the prior-year quarter.

Looking ahead
Next quarter's average estimate for revenue is $1.40 billion. On the bottom line, the average EPS estimate is $0.88.

Next year's average estimate for revenue is $5.55 billion. The average EPS estimate is $3.43.

Investor sentiment

Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on St. Jude Medical is outperform, with an average price target of $45.90.

Can your portfolio provide you with enough income to last through retirement? You'll need more than St. Jude Medical. Learn how to maximize your investment income and get "The 3 DOW Stocks Dividend Investors Need." Click here for instant access to this free report.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

St. Jude Medical, Inc. Stock Quote
St. Jude Medical, Inc.
STJ

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning service.

Stock Advisor Returns
331%
 
S&P 500 Returns
115%

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 05/21/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.